Trade with your broker
Market capitalisation, EUR | 226,300.15 m |
EPS, EUR | 1.88 |
P/B ratio | 6.60 |
P/E ratio | 38.78 |
Dividend yield | 1.79% |
Revenue, EUR | 42,374.41 m |
Net income, EUR | 5,508.28 m |
Profit margin | 13.00% |
ETF | Weight | Investment focus | Holdings | TER | Fund size (in m EUR) | Return 1Y | WKN | ISIN |
---|---|---|---|---|---|---|---|---|
Invesco NASDAQ-100 Equal Weight UCITS ETF Acc | 1.17% | Equity Technology Equal Weighted | 101 | 0.20% | 122 | +20.39% | A3EE27 | IE000L2SA8K5 |
First Trust Value Line® Dividend Index UCITS ETF Acc | 0.52% | Equity United States Dividend | 191 | 0.70% | 14 | +9.12% | A2PZMV | IE00BKVKW020 |
WisdomTree Megatrends UCITS ETF USD | 0.05% | Equity World Social/Environmental Innovation | 643 | 0.50% | 49 | - | A3EYCN | IE0000902GT6 |
Invesco EQQQ Nasdaq-100 UCITS ETF Acc | 0.32% | Equity United States Technology | 101 | 0.30% | 2,187 | +36.19% | A2N6RV | IE00BFZXGZ54 |
Invesco Nasdaq-100 ESG UCITS ETF Acc | 0.29% | Equity United States Technology Social/Environmental | 94 | 0.25% | 1,244 | +39.20% | A3CZGT | IE000COQKPO9 |
WisdomTree BioRevolution UCITS ETF USD Acc | 1.23% | Equity World Health Care Social/Environmental Biotech | 88 | 0.45% | 3 | -4.10% | A3CY21 | IE000O8KMPM1 |
iShares Nasdaq 100 UCITS ETF EUR Hedged Acc | 0.32% | Equity United States Technology | 101 | 0.36% | 690 | +28.91% | A2N34W | IE00BYVQ9F29 |
iShares Nasdaq 100 UCITS ETF (DE) | 0.32% | Equity United States Technology | 101 | 0.31% | 4,355 | +35.97% | A0F5UF | DE000A0F5UF5 |
L&G Global Thematic ESG Exclusions UCITS ETF USD Accumulating | 0.71% | Equity World Social/Environmental Innovation | 358 | 0.60% | 4 | +5.08% | A3DHPA | IE000VTOHNZ0 |
Xtrackers Nasdaq 100 UCITS ETF 1C | 0.32% | Equity United States Technology | 101 | 0.20% | 718 | +36.31% | A2QJU3 | IE00BMFKG444 |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 4.68% | Equity United States Health Care Biotech | 216 | 0.35% | 36 | +22.13% | A2JDYM | IE00BDZVHG35 |
iShares Nasdaq US Biotechnology UCITS ETF | 4.68% | Equity United States Health Care Biotech | 216 | 0.35% | 495 | +22.14% | A2DWAW | IE00BYXG2H39 |
Invesco Nasdaq-100 UCITS ETF EUR Hedged | 0.32% | Equity United States Technology | 101 | 0.35% | 265 | +29.49% | A2DT9V | IE00BYVTMS52 |
Invesco Nasdaq-100 UCITS ETF CHF Hedged | 0.32% | Equity United States Technology | 101 | 0.35% | 310 | +28.20% | A2JAN0 | IE00BYVTMT69 |
Invesco Nasdaq-100 UCITS ETF GBP Hedged | 0.32% | Equity United States Technology | 101 | 0.35% | 295 | +33.82% | A2JNFA | IE00BYVTMW98 |
Deka Nasdaq-100® UCITS ETF | 0.32% | Equity United States Technology | 101 | 0.25% | 44 | - | ETFL62 | DE000ETFL623 |
L&G Pharma Breakthrough UCITS ETF | 2.90% | Equity World Health Care Innovation | 43 | 0.49% | 17 | -1.66% | A2H9XR | IE00BF0H7608 |
Invesco EQQQ Nasdaq-100 UCITS ETF | 0.32% | Equity United States Technology | 101 | 0.30% | 7,040 | +36.99% | 801498 | IE0032077012 |
iShares Nasdaq 100 UCITS ETF (Acc) | 0.32% | Equity United States Technology | 101 | 0.33% | 14,034 | +35.41% | A0YEDL | IE00B53SZB19 |
Broker | Rating | Execution fee | Account fee | More information |
---|---|---|---|---|
free of charge | free of charge | View offer* | ||
EUR 1.50 1.50% | free of charge | View offer* | ||
EUR 1.50 1.50% | free of charge | View offer* |
Broker | Rating | Order fee | Stock savings plans | More information |
---|---|---|---|---|
EUR 0.99 | 1000 | View offer* | ||
EUR 1.00 | 2500 | View offer* | ||
free of charge | 2500 | View offer* | ||
free of charge | 500 | View offer* | ||
free of charge | 300 | View offer* |
YTD | +17.14% |
1 month | -3.37% |
3 months | +10.81% |
6 months | +13.44% |
1 year | +19.58% |
3 years | +48.24% |
5 years | - |
Since inception (MAX) | +70.83% |
2023 | -3.39% |
2022 | +23.35% |
2021 | - |
2020 | - |
Volatility 1 year | 19.36% |
Volatility 3 years | 23.14% |
Volatility 5 years | - |
Return per risk 1 year | 1.01 |
Return per risk 3 years | 0.61 |
Return per risk 5 years | - |
Maximum drawdown 1 year | -12.60% |
Maximum drawdown 3 years | -19.35% |
Maximum drawdown 5 years | - |
Maximum drawdown since inception | -19.35% |